SunRegen Healthcare AG is a pioneering biopharmaceutical company based in Basel Area of Switzerland.
We are focusing on innovative treatments for patients with severe neurological, neuromuscular and ophthalmic diseases. Our first product candidates are in development for primary optical atrophy and in evaluation for serious neurological / neuromuscular diseases like ALS, Huntington, Alzheimer`s and Parkinson`s disease.
Our team is composed of passionate, innovative and persistent founders who have track records of senior drug development & clinical research in multinational pharmaceutical company or management experiences in international technology enterprises.
Currently there are a lot of unmet medical needs. SunRegen team is full of passion to develop drugs for such needs.
SunRegen has a very solid drug development pipeline including some candidates to treat orphan diseases. SunRegen owns its unique drug discovery technology and is positioned to be the leader of drug discovery.
SunRegen Healthcare AG fits in a drug development ecosystem including the highly acknowledged CROs, research institutions, and other drug development service organizations.
We welcome investors to join us and achieve the goals of improving patients’ health together!
We welcome experienced scientists and experts in preclinical up to phase II clinical development to get in contact or send your CV to firstname.lastname@example.org